Inhibition of Heme Oxygenase-1 by Zinc Protoporphyrin IX Improves Adverse Pregnancy Outcomes in Malaria During Early Gestation

Front Immunol. 2022 May 10:13:879158. doi: 10.3389/fimmu.2022.879158. eCollection 2022.

Abstract

The enzyme heme oxygenase-1 (HO-1) has cytoprotective effects by catalyzing the degradation of heme to produce carbon monoxide, iron and biliverdin. Furthermore, HO-1 activity has been associated with successful pregnancy. On the other hand, in the context of certain inflammatory conditions, HO-1 can induce iron overload and cell death. To investigate the role of HO-1 in gestational malaria, pregnant BALB/c mice were infected with Plasmodium berghei ANKA in early, mid and late gestation. We found that malaria affected the pregnancy outcome in the three periods evaluated. However, only poor pregnancy outcomes in early pregnancy were related to HO-1 upregulation, iron overload, lipid peroxidation and necrosis of the decidua, which were prevented by HO-1 inhibition. In conclusion, HO-1 expression must be finely tuned in gestational malaria to avoid the deleterious effect of increased enzyme activity.

Keywords: HO-1; ZnPPIX.; ferroptosis; iron overload; malaria; pregnancy; uterine natural killer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Heme Oxygenase-1* / antagonists & inhibitors
  • Heme Oxygenase-1* / metabolism
  • Iron Overload
  • Lipid Peroxidation
  • Malaria* / drug therapy
  • Mice
  • Plasmodium berghei
  • Pregnancy
  • Pregnancy Complications, Parasitic / drug therapy
  • Pregnancy Outcome*
  • Protoporphyrins* / pharmacology

Substances

  • Protoporphyrins
  • zinc protoporphyrin
  • Heme Oxygenase-1